CRA consultants named top IP professionals in the 2023 IAM Strategy 300
13 CRA consultants were recognized as leading IP strategy by Intellectual Asset Management (IAM). IAM Strategy 300: The World’s Leading IP Strategists lists...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
CRA has assisted clients in intellectual property (IP) matters concerning products and services in the life sciences sector, including Hatch-Waxman and BPCIA matters. We have also addressed patent, trademark, and copyright infringement, trade secret misappropriation, and IP licensing. Our experts have quantified damages based on lost profit and reasonable royalty methods and provided opinions on irreparable harm. In addition, we have experience addressing other forms of relief, such as rescission and disgorgement.
Our understanding of the unique dynamics of different therapeutic areas informs assessments of commercial success as a secondary indicator of non-obviousness and the claimed nexus between patented technologies and product success.
13 CRA consultants were recognized as leading IP strategy by Intellectual Asset Management (IAM). IAM Strategy 300: The World’s Leading IP Strategists lists...
13 CRA consultants were recognized as leading patent professionals by Intellectual Asset Management (IAM). The IAM Patent 1000: The World’s Leading Patent...